The U.S. Food and Drug Administration's refusal to license a therapeutic device intended to help brain-injured people is raising questions about the rigour of Health Canada's approval process.
from CBC | Health News http://bit.ly/2XsERR1
The U.S. Food and Drug Administration's refusal to license a therapeutic device intended to help brain-injured people is raising questions about the rigour of Health Canada's approval process.
Aucun commentaire:
Enregistrer un commentaire